CG Oncology Study ID:
Cretostimogene grenadenorepvec (CG0070)
Non-Muscle Invasive Bladder Cancer
BOND-003 Study Patient Eligibility
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided.
Download your Doctor Discussion Guide to help guide conversations with your health care professional: